Vertex Pharmaceuticals (VRTX) Options Chain & Prices $450.00 +1.99 (+0.44%) (As of 09:15 AM ET) Add Compare Share Share Options Chain Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends VRTX Put and Call Options List 1/15/2027 12/18/2026 6/18/2026 1/16/2026 9/19/2025 7/18/2025 6/20/2025 4/17/2025 1/17/2025 12/27/2024 12/20/2024 12/13/2024 12/6/2024 11/29/2024 11/22/2024 Options Date Put and Call Options Put Options Call Options Options Type All In The Money Out of The Money Moneyness With Volume Without Volume All Volume Strike Price Min Strike Price Max Export to Excel ExpiresStrike PriceClose PricePut/CallVolumeVolume AskVolume BidOpen InterestImplied VolatilityDeltaTrades11/22/2024$415.00$33.410Call2 - - 10(+0)44.12% (-0.13%)0.973534111/22/2024$430.00$1.020Put150138103(+0)40.14% (-0.89%)-0.1256536611/22/2024$435.00$1.771Put1721322413(+1)47.40% (+7.28%)-0.1980966311/22/2024$440.00$2.974Put63133(+0)38.70% (-0.62%)-0.296068511/22/2024$445.00$4.772Put44 - 12(-1)38.46% (-0.17%)-0.414943411/22/2024$445.00$8.122Call97 - 0(+0)38.46% (-0.17%)0.5943254 Get the Latest News and Ratings for VRTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vertex Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/22/2024$450.00$7.127Put913710105(+1)38.54% (+0.47%)-0.536691811/22/2024$450.00$5.549Call4521184(+1)38.54% (+0.47%)0.468823911/22/2024$455.00$10.396Put8 - 2178(+0)38.96% (+1.30%)-0.662779311/22/2024$455.00$3.643Call3310205(+0)38.93% (+1.28%)0.349405811/22/2024$457.50$12.197Put9126(+0)39.26% (+1.76%)-0.716559411/22/2024$460.00$13.956Put604437(+4)39.59% (+2.20%)-0.7606781011/22/2024$460.00$2.318Call4662841(-1)39.59% (+2.21%)0.2478142311/22/2024$462.50$16.170Put17 - 1019(+7)40.04% (+2.74%)-0.80692311/22/2024$465.00$18.308Put1 - 15(+0)40.51% (+3.24%)-0.843111111/22/2024$465.00$1.411Call282210(+0)40.51% (+3.24%)0.165899811/22/2024$467.50$20.523Put1 - 17(+2)41.01% (+3.75%)-0.873802111/22/2024$467.50$1.108Call4130(+0)41.01% (+3.75%)0.135437411/22/2024$470.00$0.889Call2311431(+8)41.50% (+4.20%)0.112171111/22/2024$472.50$0.680Call32138(+29)42.12% (+4.76%)0.088869311/22/2024$475.00$0.545Call4 - 264(+62)42.65% (+5.19%)0.073112311/22/2024$477.50$0.427Call5 - 434(+30)43.25% (+5.67%)0.05878511/22/2024$480.00$32.331Put5 - - 9(+0)43.93% (+6.19%)-0.964209211/22/2024$480.00$0.334Call4 - 3136(+0)43.87% (+6.13%)0.047183411/22/2024$485.00$37.242Put25 - 2538(+0)45.22% (+7.08%)-0.980784311/22/2024$485.00$0.206Call2 - - 32(+0)45.16% (+7.02%)0.030326211/22/2024$487.50$0.162Call6 - 611(+0)45.81% (+7.44%)0.024307111/22/2024$490.00$42.199Put1 - - 500(+0)46.53% (+7.91%)-0.990569111/22/2024$492.50$0.098Call1 - 111(+0)47.21% (+8.32%)0.015279111/22/2024$500.00$0.049Call6 - - 27(+0)49.21% (+9.42%)0.00796311/22/2024$530.00$0.004Call3 - - 38(+0)57.09% (+12.88%)0.0006891End-of-day options data provided by Trade Alert and Intrinio. Related Companies and Tools Related Companies AMGN Options GILD Options REGN Options ALNY Options BIIB Options BGNE Options UTHR Options RPRX Options INCY Options BMRN Options Options Chain Tools Short Interest TrackerShort Interest IncreasesShort Interest DecreasesUnusual Call VolumeUnusual Put Volume This page (NASDAQ:VRTX) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredFormer CIA Advisor: Stock Market Miracle! Trump’s “Project Independence”Jim says fast-movers who act now could have the chance to turn as little as $10,000 into $265,000 by Inaugurat...Paradigm Press | SponsoredTrump won. Buy this coin now.Juan Villaverde called the top and bottom of every crypto bull market since 2012. He believes Bitcoin will ...Weiss Ratings | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredAmerica’s Pro-Crypto AgendaCash In On the Pro-Crypto America 27 experts reveal their top picks for 2025 Crypto 101 Media | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vertex Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Vertex Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.